GenMont Biotech Incorporation (TPE:3164)
17.75
-0.20 (-1.11%)
Apr 29, 2026, 1:30 PM CST
TPE:3164 Market Cap
TPE:3164 has a market cap or net worth of 1.53 billion as of April 29, 2026. Its market cap has decreased by -14.13% in one year.
Market Cap
1.53B
Enterprise Value
1.39B
Revenue
401.23M
Ranking
n/a
PE Ratio
26.89
Stock Price
17.75
Market Cap Chart
Since May 8, 2006, TPE:3164's market cap has increased from 899.18M to 1.53B, an increase of 69.79%. That is a compound annual growth rate of 2.68%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Advagene Biopharma | 1.54B |
| NeoCore Technology | 1.41B |
| Enimmune | 1.40B |
| Bio Preventive Medicine | 1.69B |
| Meribank Biotech | 1.36B |
| Abnova (Taiwan) | 1.35B |
| Great Novel Therapeutics Biotech & Medicals | 1.85B |
| Holy Stone Healthcare | 1.20B |